CNX Therapeutics
Drug Stores & Pharmacies · United Kingdom · 11-50 Employees
View Company Info for Free
Overview
Headquarters
15-19 Bloomsbury Way, London, Greater Lo...Phone Number
+44 2078212840Website
www.cnx-therapeutics.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About CNX Therapeutics
CNX Therapeutics is a specialty pharmaceutical company dedicated to improving patient lives by supplying essential medicines. They license and distribute a growing portfolio of products for central nervous system (CNS), critical care, and other medical conditions across over 60 global markets. The company emphasizes partnerships and has a strong commitment to environmental, social, and governance (ESG) practices. With a focus on patient care and a supportive work environment, CNX Therapeutics aims to be a leader in the pharmaceutical industry.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is CNX Therapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if CNX Therapeutics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on CNX Therapeutics recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
CNX Therapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once CNX Therapeutics has new funding data
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CNX Therapeutics launches new products
Click to see if CNX Therapeutics had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at CNX Therapeutics
Check out if CNX Therapeutics is spiking on competitors!
Recommended Actions
Reach out to Masked Content who joined CNX Therapeutics as Masked Content
Find more new buyers
Compare Similar Companies to CNX Therapeutics
Compare insights from companies similar to CNX Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
CNX Therapeutics
<$5M
11-50
Private
-
1997
N/A
Company Profile Activity
Activity Insights
CNX Therapeutics is experiencing very low activity levels compared to other companies in the Retail sector.
What does this means?
CNX Therapeutics is drawing exceptional interest within the Retail industry, suggesting notable developments or strong market momentum, learn more about CNX Therapeutics.
CNX Therapeutics Tech Stack
A closer look at the technologies used by CNX Therapeutics
Most Recent Scoops
Open Position
Open Position
Event
Product Marketing, Events, Training, Sales, Logistics / Supply Chain, Pharmaceuticals, Clinical Operations, Field Marketing, Manufacturing Operations, Operations
Partnership
Project
Partnership, Product Management, Business Development, Logistics / Supply Chain, Pharmaceuticals
Open Position
CNX Therapeutics News & Media
UK: Masterson replaces Lund as CFO at CNX Therapeutics - Investors in Healthcare
Claire Masterson replaces Olga Lund as CFO at CNX TherapeuticsCNX Therapeutics Announces CFO Transition: Olga Lund to depart, Claire Masterson Joins ...
London, July 3 2024: - CNX Therapeutics Limited (“CNX Therapeutics”), a speciality pharmaceutical company with a focus on improving access to essential medicines, today announced that Olga Lund will be stepping down from her role as Chief Financial Officer to take a career break and spend more time with...French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics
Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French Overseas Territories and Algeria (the “Territory”) for the antipsychotic, "Loxapac" (generic name: loxapine) and the Parkinson's disease treatment "Parkinane LP" (generic name: trihexyphenidyl hydrochloride) to CNX Therapeutics Limited. Following the signature of this agreement, a transition period had opened during which the required implementation
Read more news
Top Drug Stores & Pharmacies Companies
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CNX Therapeutics
Sign Up For FreeTo access detailed company insights
CNX Therapeutics is a specialty pharmaceutical company dedicated to improving patient lives by supplying essential medicines. They license and distribute a growing portfolio of products for central nervous system (CNS), critical care, and other medical conditions across over 60 global markets. The company emphasizes partnerships and has a strong co... Read More
